These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6470675)

  • 21. Characterization of lipid A and polysaccharide moieties of the lipopolysaccharides from Vibrio cholerae.
    Raziuddin S
    Biochem J; 1977 Oct; 167(1):147-54. PubMed ID: 588246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amino sugar contents and phage inactivating properties of lipopolysaccharide from cholera and El Tor vibrios.
    Maiti M; Sur P; Chatterjee SN
    Ann Microbiol (Paris); 1977 Jan; 128A(1):35-9. PubMed ID: 869403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatty acid composition of lipopolysaccharides of Vibrio cholerae 35A3 (Inaba), NIB 90 (Ogawa), and 4715 (Nag).
    Hisatsune K; Kondo S; Kawata T; Kishimoto Y
    J Bacteriol; 1979 Apr; 138(1):288-90. PubMed ID: 438134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The wavB gene of Vibrio cholerae and the waaE of Klebsiella pneumoniae codify for a beta-1,4-glucosyltransferase involved in the transfer of a glucose residue to the L-glycero-D-manno-heptose I in the lipopolysaccharide inner core.
    Izquierdo L; Merino S; Coderch N; Regué M; Tomás JM
    FEMS Microbiol Lett; 2002 Nov; 216(2):211-6. PubMed ID: 12435504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacteriophage CP-T1 of Vibrio cholerae. Identification of the cell surface receptor.
    Guidolin A; Manning PA
    Eur J Biochem; 1985 Nov; 153(1):89-94. PubMed ID: 4065151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The heterogeneity of lipopolysaccharides from Citrobacter 023 serotype.
    Katzenellenbogen E
    Arch Immunol Ther Exp (Warsz); 1988; 36(2):119-28. PubMed ID: 2467634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a flagellar sheath protein of Vibrio cholerae.
    Hranitzky KW; Mulholland A; Larson AD; Eubanks ER; Hart LT
    Infect Immun; 1980 Feb; 27(2):597-603. PubMed ID: 7380541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunochemical studies of the lipopolysaccharides of Vibrio cholerae: constitution of O specific side chain and core polysaccharide.
    Raziuddin S
    Infect Immun; 1980 Jan; 27(1):211-5. PubMed ID: 7358427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vibrio cholerae O139 Bengal possesses a capsular polysaccharide which may confer increased virulence.
    Weintraub A; Widmalm G; Jansson PE; Jansson M; Hultenby K; Albert MJ
    Microb Pathog; 1994 Mar; 16(3):235-41. PubMed ID: 8090081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and characterization of protective anti-LPS nanobody against V. cholerae O1 recognizing Inaba and Ogawa serotypes.
    Ebrahimizadeh W; Mousavi Gargari S; Rajabibazl M; Safaee Ardekani L; Zare H; Bakherad H
    Appl Microbiol Biotechnol; 2013 May; 97(10):4457-66. PubMed ID: 23135228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunochemical studies on lipopolysaccharide from agglutinable and non-agglutinable vibrios.
    Guhathakurta B; Dutta GC
    Appl Microbiol; 1974 Apr; 27(4):634-9. PubMed ID: 4207760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction of an engineered bivalent vaccine strain consisting of Vibrio cholerae CT-B and LPS-O antigens.
    Yu X; Ma Q
    Chin J Biotechnol; 1994; 10(4):225-32. PubMed ID: 7780018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-function relationship: biological activities of the lipopolysaccharides and lipid A from Vibrio cholerae.
    Raziuddin S
    J Infect Dis; 1979 Oct; 140(4):590-5. PubMed ID: 512418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation and characterization of the exo-enterotoxin of Vibrio cholerae strain 110 Cal.
    Chukwumah EI; Akinwande AI; Akinrimisi EO; Odugbemi T
    West Afr J Med; 1995; 14(1):1-5. PubMed ID: 7626525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between structure and antigenicity of O1 Vibrio cholerae lipopolysaccharides.
    Hisatsune K; Hayashi M; Haishima Y; Kondo S
    J Gen Microbiol; 1989 Jul; 135(7):1901-7. PubMed ID: 2482336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lysis of Vibrio cholerae cells: direct isolation of the outer membrane from whole cells by treatment with urea.
    Lohia A; Chatterjee AN; Das J
    J Gen Microbiol; 1984 Aug; 130(8):2027-33. PubMed ID: 6470676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Location of fructose in lipopolysaccharide isolated from 01 Vibrio cholerae NIH 41R.
    Kondo S; Haishima Y; Hisatsune K
    FEMS Microbiol Lett; 1993 Jan; 106(1):93-8. PubMed ID: 8440469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of toxin biosynthesis by plasmids in Vibrio cholerae.
    Khan AA; Srivastava R; Sinha VB; Srivastava BS
    J Gen Microbiol; 1985 Oct; 131(10):2653-7. PubMed ID: 3934328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative study of the properties of Vibrio cholerae O139, O1 and other non-O1 strains.
    Nandy RK; Sengupta TK; Mukhopadhyay S; Ghose AC
    J Med Microbiol; 1995 Apr; 42(4):251-7. PubMed ID: 7707332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural investigations on the lipopolysaccharide isolated from Vibrio cholera Ogawa G-2102.
    Majumder M; Mukherjee AK; Guhathakurta B; Dutta A; Sasmal D
    Carbohydr Res; 1982 Oct; 108(2):269-78. PubMed ID: 7139661
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.